Pharmaceutical Sales Whistleblower Sheds Light on Off-Label Marketing Scheme

Endo Pharmaceuticals, makers of the Lidoderm patch, have agreed to pay $172 million to settle claims it improperly labeled and marketed the product.Image source: It is unlawful for a pharmaceutical company to market a drug for purposes beyond those that have been approved by the Food and Drug Administration. When a company [...]

By | 2018-03-27T09:14:01+00:00 February 28th, 2014|Healthcare Fraud|